ROCKVILLE, Md.--(BUSINESS WIRE)--May 11, 2006--Celera Genomics (NYSE:CRA - News), an Applera Corporation business, the University of California, San Francisco (UCSF), Cleveland Clinic, Case Western Reserve University and Brigham Young University, today announced a publication describing two novel genetic markers associated with an increased risk for myocardial infarction (MI), or heart attack. Neither of the two gene variants, VAMP8 and HNRPUL1, has previously been associated with MI. This paper will appear in the July 2006 edition of Arteriosclerosis, Thrombosis and Vascular Biology, and is currently available on the publication’s website at http://atvb.ahajournals.org/.
